diphenyl has been researched along with Coronary Heart Disease in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| URBINATI, G | 1 |
| DELLA PORTA, P; LUCCHINI, CR | 1 |
| MALTEZ, JS | 1 |
| ANFOSSI, F; ANSELMINO, A; BERT, G; BIANCO, A; MIGHELI, B; PUPITA, F | 1 |
| PRETOLANI, E | 1 |
| ANSELMINO, A; MILONE, PA | 1 |
| CESARI, L | 1 |
| DE FELICE, D; ROSSETTO, L | 1 |
| DE IASI, A | 1 |
| DOBREANU-ENESCU, V; HARNAGEA, P; TEODORINI, S | 1 |
| PICCINELLI, O | 1 |
| BELLONCANEIRO, JM; TORNER SOLER, M; TRILLA SANCHEZ, E | 1 |
| MENCI, S | 1 |
| BOZZA, G; CESARI, A; PASSERELLI, A; RIZZI, R; VANGELISTA, A | 1 |
| ECKERT, H; GAWELLEK, F | 1 |
| FRANZINI, C; MONTEROSSO, A; TURRI, C | 1 |
| BRAT, A; GIARDINA, A; ZOLI, A | 1 |
| PINACCI, U; RIVALI, A | 1 |
18 other study(ies) available for diphenyl and Coronary Heart Disease
| Article | Year |
|---|---|
[3,3-Diphenyl-N-(alpha-methylphenethyl)-propylamine].
Topics: Biphenyl Compounds; Coronary Disease; Enzyme Inhibitors; Propylamines; Vasodilator Agents | 1961 |
[3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine.] (Segontin) in syndromes of coronary insufficiency. Preliminary note].
Topics: Anti-Arrhythmia Agents; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Humans; Prenylamine; Propylamines; Syndrome; Vasodilator Agents | 1961 |
[3'-phenyl-propyl-(2')]-1, 1-diphenyl-propyl-(3)-amine (Segontin).
Topics: Amines; Biphenyl Compounds; Coronary Disease; Diphenhydramine; Prenylamine | 1963 |
[Experimental and clinical observations on the action of a new anti-angina drug: 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine lactate or FPDFPA].
Topics: Biphenyl Compounds; Cardiovascular Agents; Coronary Disease; Humans; Lactates; Lactic Acid; Prenylamine; Propylamines | 1963 |
[Clinical evaluation of a preparation with antistenocardiac action, 3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine].
Topics: Biphenyl Compounds; Coronary Disease; Humans; Prenylamine; Propylamines | 1963 |
[Clinical and electrocardiographic observations on the treatment of coronary insufficiency with phenyl-propyl-diphenyl-propylamine].
Topics: Angina Pectoris; Biphenyl Compounds; Coronary Disease; Electrocardiography; Humans; Prenylamine; Propylamines | 1963 |
[Clinical observations on the use of a new synthetic agent (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine, Segontin) in coronary insufficiency syndromes].
Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Prenylamine; Propylamines; Sympatholytics; Syndrome; Vasodilator Agents | 1962 |
[Clinical experimentation with a new substance (3,3-diphenyl-N-(alpha-methylphenethyl)-propylamine in syndromes caused by coronary insufficiency].
Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Propylamines; Sympatholytics; Syndrome; Vasodilator Agents | 1962 |
[Clinical and electrocardiographic considerations on the use of a new synthesis (phenyl-propyl-diphenyl-propyl-amine) in the therapy of syndromes of coronary insufficiency in urologic patients].
Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Electrocardiography; Humans; Prenylamine; Syndrome; Urology | 1963 |
[Treatment with phenyl-propyl-diphenyl-propyl-amine (Segontin Hoechst) in coronary disease].
Topics: Amines; Biphenyl Compounds; Coronary Disease; Diphenhydramine; Humans; Prenylamine | 1963 |
[N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
Topics: Biphenyl Compounds; Cardiomyopathies; Coronary Artery Disease; Coronary Disease; Phenethylamines; Propylamines; Vasodilator Agents | 1961 |
[CLINICAL TRIALS WITH PHENYL-DIPHENYL-PROPYL-AMINE IN CORONARY INSUFFICIENCY].
Topics: Angina Pectoris; Biphenyl Compounds; Cholesterol; Coronary Disease; Electrocardiography; Lipid Metabolism; Prenylamine; Statistics as Topic; Toxicology | 1963 |
[CLINICO-ELECTROCARDIOGRAPHIC OBSERVATIONS ON THE ACTIVITY OF N-(3)-PHENYLPROPYL-(2)-1,1-DIPHENYL-PROPYL-(3)-AMINE (F.P.D.P.A.) IN CORONARY INSUFFICIENCY].
Topics: Biomedical Research; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Electrocardiography; Humans; Prenylamine | 1964 |
[CONSIDERATIONS ON THE THERAPY OF CORONARY INSUFFICIENCY WITH PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (FPDPA)].
Topics: Biphenyl Compounds; Blood Chemical Analysis; Blood Glucose; Blood Pressure; Cholesterol; Coronary Disease; Electrocardiography; Exercise Test; Geriatrics; Heart Function Tests; Lipids; Nitrogen; Pharmacology; Prenylamine | 1964 |
[CATECHOLAMINE EXCRETION AND THE CLINICAL PICTURE IN THE MANAGEMENT OF CARDIAC INFARCTION AND CORONARY INSUFFICIENCY WITH N 3-PHENYLPROPYL -(2) 1, 1-DIPHENYL-PROPYL-(3)-AMINE].
Topics: Biphenyl Compounds; Catecholamines; Coronary Disease; Drug Therapy; Epinephrine; Geriatrics; Infarction; Myocardial Infarction; Nitrites; Norepinephrine; Prenylamine; Urine | 1964 |
[PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (SEGONTIN) IN TREATMENT OF SYNDROMES DUE TO CORONARY INSUFFICIENCY IN PATIENTS OVER SEVENTY].
Topics: Amines; Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Drug Therapy; Geriatrics; Humans; Prenylamine; Syndrome; Toxicology | 1964 |
[METABOLIC EFFECTS OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN THE HEALTHY MAN AND IN THE PATIENT WITH ISCHEMIC HEART DISEASE. I. CLINICAL AND EXPERIMENTAL PHARMACOLOGY OF FEDIPRA].
Topics: Biphenyl Compounds; Coronary Artery Disease; Coronary Disease; Myocardial Ischemia; Pharmacology; Prenylamine; Toxicology | 1963 |
[NEW CLINICO-EXPERIMENTAL CONFIRMATIONS ON THE EFFICACY OF PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE IN CORONARY DISEASES].
Topics: Amines; Biphenyl Compounds; Coronary Disease; Electrocardiography; Humans; Vasodilator Agents | 1965 |